Neomycin A Sulfate (Neamine), EvoPure® is a highly purified Neomycin compound. Neomycin A has been found to have the lowest antibacterial activity (~ 10% of the activity of Neomycin B). Neomycin A can inhibit angiogenin translocation in tumor cell nuclei effectively inhibiting tumor growth. Neomycin A has a lower toxicity profile than other Neomycin components making it a favorable tool in cancer research.
We also offer:
- Neomycin Sulfate, USP (N003)
- Neomycin Sulfate, EP (N012)
- Neomycin B Sulfate, EvoPure® (N019)
- Neomycin C Sulfate, EvoPure® (N022)
- Neomycin solution (10 mg/ml Neomycin in 0.9% NaCl)(N027)
Custom manufacturing and testing: We are able to prepare custom Neomycin components for your unique specifications for use in cell culture, upstream biopharma manufacturing, or cancer research. Additionally, we offer additional testing including endotoxin content, arsenic content, cell line testing, spectral analysis, and more. For more information, please contact us.